MSB 2.08% 94.0¢ mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-488

  1. 16,945 Posts.
    lightbulb Created with Sketch. 2409
    Ten of course you and your fellow travellers were insisting that the FDA wouldn't bother sendinga team to inspect the manufacturing facility unless they'd already decided to approve Remestemcel...

    "You treat users here like they are stupid..."

    I think you have that reversed.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.0¢
Change
-0.020(2.08%)
Mkt cap ! $1.073B
Open High Low Value Volume
95.5¢ 97.0¢ 93.5¢ $1.424M 1.507M

Buyers (Bids)

No. Vol. Price($)
8 29390 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 14089 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.